Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

Hyundai Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is December - November.

Total Valuation

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Nov 3, 2026	Nov 30, 2013	Nov 30, 2012	Nov 30, 2011	Nov 30, 2010	Nov 30, 2009
Market Capitalization	180,459	42,443	36,229	27,905	38,340	55,972
Market Cap Growth	76.45%	17.15%	29.83%	-27.22%	-31.50%	-0.39%
Enterprise Value	-	48,583	43,620	36,761	49,208	69,151
Last Close Price	6410.00	1581.88	1318.83	992.31	1318.31	1788.54

Price Ratios

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Nov 3, 2026	Nov 30, 2013	Nov 30, 2012	Nov 30, 2011	Nov 30, 2010	Nov 30, 2009
PE Ratio	108.06	30.00	-	53.65	12.92	33.50
PS Ratio	1.67	0.39	0.35	0.24	0.34	0.46
PB Ratio	1.78	0.42	0.36	0.27	0.41	0.60
P/TBV Ratio	1.83	0.43	0.37	0.28	0.42	0.61
P/FCF Ratio	31.61	7.43	-	10.79	-	-
P/OCF Ratio	22.70	5.34	-	4.45	14.32	-

EV Ratios

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Nov 3, 2026	Nov 30, 2013	Nov 30, 2012	Nov 30, 2011	Nov 30, 2010	Nov 30, 2009
EV/Sales Ratio	-	0.45	0.43	0.32	0.44	0.56
EV/EBITDA Ratio	-	11.30	-	6.20	35.00	18.32
EV/EBIT Ratio	-	22.21	-	10.62	-	59.08
EV/FCF Ratio	-	8.51	-	14.22	-	-

Financial Efficiency

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Nov 3, 2026	Nov 30, 2013	Nov 30, 2012	Nov 30, 2011	Nov 30, 2010	Nov 30, 2009
Debt / Equity Ratio	0.21	0.21	0.29	0.27	0.24	0.25
Debt / EBITDA Ratio	4.83	4.83	-	4.69	15.65	6.23
Debt / FCF Ratio	3.63	3.63	-	10.76	-	-
Net Debt / Equity Ratio	0.06	0.06	0.13	0.13	0.12	0.17
Net Debt / EBITDA Ratio	1.42	1.42	-6.46	2.34	7.60	4.20
Net Debt / FCF Ratio	1.07	1.07	-3.05	5.36	-8.43	-1.72
Asset Turnover	0.74	0.74	0.67	0.79	0.84	0.93
Inventory Turnover	3.00	3.00	3.07	4.41	4.42	4.89
Quick Ratio	1.62	1.62	1.41	1.55	1.80	1.64
Current Ratio	2.20	2.20	1.97	1.94	2.21	2.07
Return on Equity (ROE)	1.45%	1.45%	-4.75%	0.55%	3.21%	1.80%
Return on Assets (ROA)	0.93%	0.93%	-1.76%	1.50%	-0.42%	0.55%
Return on Invested Capital (ROIC)	2.04%	1.99%	-3.75%	0.95%	-0.65%	0.98%
Return on Capital Employed (ROCE)	2.00%	2.00%	-4.10%	3.10%	-0.90%	1.20%

Yields

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Nov 3, 2026	Nov 30, 2013	Nov 30, 2012	Nov 30, 2011	Nov 30, 2010	Nov 30, 2009
Earnings Yield	0.93%	3.33%	-13.39%	1.86%	7.74%	2.99%
FCF Yield	3.16%	13.45%	-11.47%	9.27%	-3.31%	-16.46%
Dividend Yield	0.46%	-	-	-	2.75%	2.19%
Payout Ratio	62.32%	62.32%	-	202.97%	41.25%	95.71%
Buyback Yield / Dilution	-0.09%	-0.08%	0.90%	0.97%	2.94%	7.44%
Total Shareholder Return	0.38%	-0.08%	0.90%	0.97%	5.69%	9.62%

Data Source: S&P Global Market Intelligence Last updated: Jan 27, 2014

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error